A case of late onset myoclonic epilepsy in Down syndrome (LOMEDS)

Research output: Contribution to journalArticle

Abstract

Myoclonic epilepsy is being increasingly recognized as a late onset complication in middle-aged or elderly patients with Down syndrome, in association with acute cognitive decline or dementia. We report a case of late onset myoclonic epilepsy in Down syndrome (LOMEDS) with acute cognitive decline, aged 45 year-olds. Although her intelligence condition remained poor with one to two-words sentences and difficult in following commands even after treatment, induction of levetiracetam and lamotorigin resulted in rapid, sustained seizure freedom and upgrading social activity with no adverse events. A combination of levetiracetam and lamotorigin appear to be effective for LOMEDS, and could be considered as first line agents for this special condition.

Original languageEnglish
Pages (from-to)564-567
Number of pages4
JournalJournal of the Japan Epilepsy Society
Volume32
Issue number3
DOIs
Publication statusPublished - Jan 1 2015

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'A case of late onset myoclonic epilepsy in Down syndrome (LOMEDS)'. Together they form a unique fingerprint.

  • Cite this